Public pages use no advertising trackers. The secure portal uses an essential session cookie and the service providers described in our privacy policy.
What to do after receiving a privacy demand letter. Read the guide → Public pages use no advertising trackers; the secure portal uses an essential session cookie.
Court rulings and agency actions on website and app tracking
Courts, the Federal Trade Commission, the Department of Health and Human Services and state attorneys general keep acting on information sent through tracking tools on websites and apps, including health information. Each entry below states what the court or agency did in one sentence and links to the primary document. Rulings for defendants are listed alongside rulings for plaintiffs, newest first.
Published by Privacy Resolve from public records. It does not cover our own matters.
40 entries: 29 court rulings and 11 agency actions. Each shows the date its source was last checked and links to a full analysis of it.
Rulings by issue
How many entries bear on each issue, and whether each one supports a website tracking claim on it, limits one, or gives context. Select a count to list those entries.
Whether the people suing were harmed in a way that lets a federal court hear the claim.
Interception
Whether a tracking tool acquired a communication as it was sent, who did it, and whether it was intentional.
Contents
Whether what was sent, such as page addresses, searches and clicks, counts as the contents of a communication.
Party exception
Whether the website, as a party to the visit, could consent to the tracking under 18 U.S.C. § 2511(2)(d).
Crime-tort exception
Whether a communication was intercepted for the purpose of a criminal or tortious act, which removes the party exception.
Consent
Whether visitors agreed to the tracking through banners, privacy policies or terms.
Health information
What counts as individually identifiable health information when it is sent through tracking tools.
HIPAA
How HIPAA, its criminal provision at 42 U.S.C. § 1320d-6 and HHS guidance bear on tracking.
State wiretap laws
State interception statutes, such as California Penal Code § 631 and the Washington Privacy Act.
State privacy laws
Other state privacy statutes and claims, such as medical information and health records acts and the CCPA.
Consumer protection
Deception and unfair practice claims, such as under the FTC Act and N.Y. General Business Law § 349.
Class certification
Whether claims can go forward on behalf of a whole class of website or app users.
Damages
What must be shown to recover money, including statutory damages and proof of actual loss.
Agency penalties and orders
Civil penalties, payments and conduct terms that regulators obtained.
Health Breach Notification Rule
The FTC rule that can treat an unauthorized disclosure of health app data as a breach that requires notice.
Supports
Strengthens a website tracking claim on this issue.
Limits
Narrows or defeats a website tracking claim on this issue.
Context
Bears on the issue without deciding it either way.
Find entries
Type
Outcome
Issue
Showing 40 of 40 entries.
2026
· Court ruling
In re Meta Pixel Healthcare Litigation
U.S. District Court for the Northern District of California, No. 3:22-cv-03580-WHO, ECF No. 1425
For plaintiffs
The court granted the motion to certify four classes of Facebook users suing Meta, covering patient-status button clicks, patient health information, prescription drug information and device intrusion, except for a limited class under section 631 of the California Invasion of Privacy Act and a redefined class under the California Comprehensive Computer Data Access and Fraud Act.
The court held that whether these categories of information are contents under the federal Wiretap Act or section 631 is a common question, and it did not decide the crime-tort exception.
U.S. Court of Appeals for the Fifth Circuit, No. 25-10784
For plaintiffs
The court held that the unauthorized disclosure of website visitors' individually identifiable health information to an advertising platform through a tracking pixel is a concrete injury that gives them standing, that such information need not reveal a specific diagnosis if it relates to a condition or the provision of care, and reversed a dismissal that had rested on findings that no such information was shared.
The court did not decide the Wiretap Act merits, the crime-tort exception or the state law claims, and remanded the case.
The court held that the Washington Privacy Act provision barring interception of private communications between two or more individuals does not reach a visitor's searches and clicks on a hospital's public website, because each of those communications involved only one individual and the hospital's own system.
The court limited its review to the hospital's public website and did not address the patient portal or claims under other Washington laws.
U.S. District Court for the District of Massachusetts, No. 1:25-cv-10105-GAO, ECF No. 49
For defendants
The court dismissed the federal Wiretap Act claim, holding that the complaint supported only an inference that the hospital used its tracking tools for its own business and marketing interests, not that it was primarily or determinatively motivated to violate the privacy of patients or other website users.
The court also denied the motion to amend.
Later history: A notice of appeal was filed on October 29, 2026 (ECF No. 52).
U.S. District Court for the District of Massachusetts, No. 1:25-cv-10081-NMG, ECF No. 92
For defendants
The court dismissed the federal Wiretap Act count, holding that the allegations supported at most an inference that the hospital was aware it might disclose private information, not that it was primarily or determinatively motivated to do so.
Later history: Appeal filed on October 21, 2026 (ECF No. 95) and pending.
U.S. District Court for the District of Minnesota, No. 0:25-cv-03129-PJS-LIB, ECF No. 30
Mixed ruling
The court denied the motion to dismiss the federal Wiretap Act claim, holding that a disclosure alleged to violate HIPAA is a separate act that can trigger the crime-tort exception and that a motive of financial gain does not make the exception inapplicable, and it dismissed the invasion of privacy and Minnesota Health Records Act claims with prejudice.
U.S. Court of Appeals for the Third Circuit, No. 24-3173
Mixed ruling
The court held that patients who alleged their health care provider secretly shared their individually identifiable health information with a third party have standing, because that harm is analogous to an intrusion upon seclusion, but it affirmed the dismissal of their second amended complaint with prejudice and the denial of their motion to reopen the judgment.
The court said it did not address whether the allegations state a claim.
U.S. District Court for the Eastern District of California, No. 2:25-cv-03388-WBS-SCR
For defendants
The court dismissed with prejudice, for lack of standing, a suit over trackers on a health insurer's website, holding that the button clicks, page visits and similar data collected on one visit to general health insurance pages, where the only entry was a ZIP code, were non-sensitive browsing activity, as the plaintiff did not allege that the trackers captured searches for physicians, conditions, appointments or patient portal use.
Vita v. Beth Israel Deaconess Medical Center, Inc.
U.S. District Court for the District of Massachusetts, No. 1:25-cv-11383-JEK, ECF No. 47
For plaintiffs
The court denied the hospital's motion to dismiss a federal Wiretap Act claim by a website user who was not a patient, holding that her communications about searching for providers and specific medical procedures were medical information of a highly intimate or personal nature under the Massachusetts privacy statute and that the crime-tort exception applies at the pleading stage, and it dismissed her breach of confidence claim.
The federal claim was added after the Supreme Judicial Court of Massachusetts held in 2024, in the same case, that the hospital's conduct was not prohibited by the Massachusetts Wiretap Act.
U.S. District Court for the Northern District of Georgia, No. 1:25-cv-06353-TWT, ECF No. 35
For defendants
The court dismissed the federal Wiretap Act claim over tracking tools on an urgent care booking website, holding that the website operator's party exception applied because the torts offered for the crime-tort exception, negligence and breach of fiduciary duty, were not separate from the interception itself.
The dismissal was without prejudice, with fourteen days to file a second amended complaint.
U.S. District Court for the District of Massachusetts, No. 1:25-cv-10343-PBS, ECF No. 82
For plaintiffs
Following Baystate, the court denied the hospital's motion to dismiss a federal Wiretap Act claim over third-party tracking on its website that captured clicks on pages about specific medical care, site searches, physician searches and appointment requests, reaching the same conclusion on the crime-tort exception.
U.S. District Court for the District of Massachusetts, No. 1:25-cv-10337-JEK, ECF No. 42
For plaintiffs
The court denied the hospital's motion to dismiss a federal Wiretap Act claim over a tracking pixel and an analytics tool on its website, holding that the patient plausibly alleged an interception for the purpose of violating the Massachusetts privacy statute and that whether the hospital acted for marketing, for an unlawful purpose or both is a question of fact.
U.S. District Court for the District of Massachusetts, No. 4:25-cv-40003-ADB, ECF No. 43
For defendants
The court dismissed the federal Wiretap Act claim, holding that allegations that the defendants purposefully installed tracking tools and disclosed information to advertising and analytics companies did not support an inference that they acted for the criminal and tortious purposes the plaintiffs specified.
The dismissal was without prejudice and with leave to amend.
U.S. District Court for the Western District of Washington, No. 2:25-cv-01831-JHC, ECF No. 16
For defendants
The court dismissed the complaint, holding that it did not plead facts allowing an inference that the defendant intercepted the plaintiff's health-related information for the purpose of committing a criminal or tortious act separate from the disclosure itself.
The dismissal was without prejudice and with leave to amend.
U.S. District Court for the Northern District of California, No. 3:23-cv-05561-VC, ECF No. 167
For defendants
On summary judgment, the court held that the event data an advertising platform obtained from the provider's website was the contents of a communication as a matter of law, but it entered judgment for the provider on the California Invasion of Privacy Act claim because the platform did not read, attempt to read or attempt to learn those contents while they were in transit.
The court also granted the provider summary judgment on the claims under the California Confidentiality of Medical Information Act and for unjust enrichment.
U.S. District Court for the Southern District of Texas, No. 4:24-cv-00775, ECF No. 63
For defendants
The court granted summary judgment to the hospital, holding that the crime-tort exception did not apply because there was no evidence the hospital knew it was disclosing individually identifiable health information, and that the commercial advantage provision of 42 U.S.C. § 1320d-6 only raises the penalty for a knowing disclosure.
U.S. District Court for the Northern District of California, No. 3:21-cv-00757-JD
For plaintiffs
A jury found Meta Platforms, Inc. liable under section 632 of the California Invasion of Privacy Act for obtaining Flo app users' menstrual and pregnancy information through its software development kit without their consent.
Later history: The court denied Meta's post-trial motions on September 17, 2025. At an October 29, 2026 hearing it took the Flurry, Google and Flo Health settlements, $59.5 million combined, under submission, noted that the parties agree class members should receive $5,000 each under California Penal Code section 637.2, and said it expects to enter final judgment on the class claim against Meta by January 2027 at the latest.
The People of the State of California v. Healthline Media, LLC
California Attorney General; Superior Court of California, County of San Francisco, No. CGC-25-626794
Agency action
The Attorney General announced the largest settlement to date under the California Consumer Privacy Act, $1.55 million in civil penalties, resolving allegations that Healthline's online tracking technology on its health information website failed to let consumers opt out of targeted advertising and shared data with third parties, including data suggesting a person may have a serious health condition, and prohibiting Healthline from sharing article titles that reveal a consumer may have already been diagnosed with a medical condition.
The complaint, filed the same day, pleads the California Consumer Privacy Act and the Unfair Competition Law.
U.S. District Court for the Southern District of New York, No. 7:23-cv-11305 (NSR), ECF No. 38
For plaintiffs
The court denied the motion to dismiss the federal Wiretap Act claim, holding that allegations that the defendant intercepted users' health and personal information for the purpose of knowingly disclosing it without authorization for marketing, an act punishable under 42 U.S.C. § 1320d-6, invoke the crime-tort exception.
The court dismissed four other counts without prejudice.
U.S. District Court for the Northern District of Illinois, No. 1:23-cv-14515, ECF No. 53
Mixed ruling
The court held that a disclosure alleged to violate HIPAA is a violation of law independent of the federal Wiretap Act, which is enough for the crime-tort exception, and that nothing in the statute's text puts conduct outside its reach because a person acted for financial reasons.
Later history: Reconsideration denied and the question certified for interlocutory appeal on March 3, 2026 (ECF No. 71). The Seventh Circuit granted permission to appeal on April 9, 2026, and the appeal, No. 26-1742, is pending.
U.S. District Court for the Western District of Washington, No. 2:23-cv-01548-JHC, ECF No. 62
Mixed ruling
In a suit by pharmacy customers, the court denied Costco's motion to dismiss the federal Wiretap Act, California Invasion of Privacy Act and several other claims, holding that their searches sent to an advertising platform were contents of communications and that the crime-tort exception can apply when data is intercepted for financial gain, but it dismissed the Washington Privacy Act claim.
U.S. District Court for the Southern District of New York, No. 7:23-cv-06950 (NSR), ECF No. 28
Mixed ruling
The court denied the motion to dismiss the federal Wiretap Act claim, holding that the plaintiffs plausibly alleged the hospital intended to transmit their health and personal information without consent for commercial purposes, a disclosure HIPAA makes a crime, which satisfied the crime-tort exception at the pleading stage.
Later history: The plaintiffs voluntarily dismissed the case without prejudice on July 25, 2025.
U.S. District Court for the Northern District of Illinois, No. 1:24-cv-01404, ECF No. 47
Mixed ruling
The court denied the motion to dismiss the federal Wiretap Act count, holding that the stated purpose of improving marketing and revenue could not be detached from the alleged disclosure of patients' individually identifiable health information and that the plaintiffs plausibly alleged an intent to violate HIPAA.
Later history: The federal case was dismissed by stipulation and refiled for settlement in state court, where a settlement of up to $18,469,389.50 received final approval and the action was dismissed with prejudice, Donnelly v. Aspen Dental Management, Inc., No. 2025LA000036 (Ill. Cir. Ct. Sangamon Cnty. Oct. 20, 2025).
U.S. District Court for the Northern District of Georgia, No. 1:23-cv-05416-TWT, ECF No. 46
For defendants
The court dismissed the patients' federal Wiretap Act and invasion of privacy claims with prejudice and their other claims without prejudice, holding among other things that there is no intrusion upon privacy when a patient voluntarily provides personally identifiable and protected health information to his or her health care provider.
Later history: Reconsideration denied, with leave to amend refused, on December 10, 2024 (ECF No. 51).
U.S. District Court for the Southern District of New York, 742 F. Supp. 3d 369, No. 1:23-cv-09485-PAE
For plaintiffs
The court denied the motion to dismiss a federal Wiretap Act claim over advertising tracking code on a health system's website and patient portal, holding the crime-tort exception plausibly alleged because disclosing individually identifiable health information for commercial advantage would violate 42 U.S.C. § 1320d-6.
Later history: The case settled for $5,256,588, with final approval on November 4, 2025 (ECF No. 79).
U.S. District Court for the Northern District of Texas, 738 F. Supp. 3d 780, No. 4:23-cv-01110-P
For plaintiffs
The court declared unlawful and vacated the part of HHS's March 18, 2024 revised bulletin on online tracking technologies that treated an IP address combined with a visit to an unauthenticated public webpage addressing specific health conditions or health care providers as individually identifiable health information, holding it was issued in clear excess of HHS's authority under HIPAA, and left the rest of the bulletin in place.
Later history: HHS appealed, and the Fifth Circuit dismissed the appeal on HHS's own motion on September 4, 2024, No. 24-10775.
Federal Trade Commission, through the Department of Justice; U.S. District Court for the Southern District of Florida, No. 1:24-cv-21376-JLK
Agency action
The court entered a consent judgment requiring the telehealth company to pay $5,087,252.89 for consumer refunds and permanently banning it from using or disclosing consumers' personal and health information to third parties for most marketing or advertising purposes, settling charges that it gave sensitive information of nearly 3.2 million consumers to third parties, including advertising platforms, through tracking tools.
The FTC announced the proposed order on April 15, 2024, with a $10 million civil penalty suspended after a $2 million payment. Cerebral did not admit or deny the allegations.
Source: FTC case page. Checked on November 10, 2026.
Federal Trade Commission, through the Department of Justice; U.S. District Court for the District of Columbia, No. 1:24-cv-01034-BAH
Agency action
The court entered an order banning the alcohol addiction treatment service from disclosing health information for advertising and requiring users' affirmative consent before sharing health information with third parties for any other purpose, with a $2.5 million civil penalty suspended due to the company's inability to pay, over allegations that it disclosed users' health information to advertising platforms through pixels and other tracking technologies without consent after promising to keep it confidential.
The FTC announced the case on April 11, 2024, under the FTC Act and the Opioid Addiction Recovery Fraud Prevention Act.
Source: FTC case page. Checked on November 10, 2026.
U.S. District Court for the Central District of California, 733 F. Supp. 3d 876, No. 5:23-cv-01933
Mixed ruling
The court denied the motion to dismiss the federal Wiretap Act and California Invasion of Privacy Act claims, holding that even where a defendant is arguably motivated by monetary gain, the crime-tort exception may apply if the plaintiffs adequately allege that its conduct violated state privacy law.
The court dismissed the negligence and several consumer statute claims with leave to amend.
Health Breach Notification Rule, 16 C.F.R. Part 318 (final rule)
Federal Trade Commission, 89 Fed. Reg. 47028 (May 30, 2024)
Agency action
By a 3-2 vote, the FTC finalized changes to the Health Breach Notification Rule that make clear it applies to health apps and similar technologies not covered by HIPAA and that a breach of security includes an unauthorized disclosure of identifiable health information, not only a data security breach.
U.S. District Court for the Western District of New York, No. 6:23-cv-06027-FPG, ECF No. 24
Mixed ruling
The court held it plausible that information sent when a website user tries to schedule an appointment with a physician is individually identifiable health information, so the plaintiffs plausibly alleged that the defendant's purpose was to commit an act punishable under 42 U.S.C. § 1320d-6, knowingly disclosing that information without authorization for marketing.
Later history: The case settled, and the court granted final approval on August 21, 2025 (ECF No. 64).
Use of Online Tracking Technologies by HIPAA Covered Entities and Business Associates (revised bulletin)
U.S. Department of Health and Human Services, Office for Civil Rights
Guidance
The Office for Civil Rights revised its December 2022 bulletin, which states that regulated entities may not use tracking technologies in a way that results in impermissible disclosures of protected health information to tracking technology vendors, and that disclosures to those vendors for marketing without HIPAA-compliant authorizations are impermissible.
Later history: On June 20, 2024, American Hospital Association v. Becerra vacated the part of the bulletin covering an IP address combined with a visit to an unauthenticated public page about specific health conditions or providers, and the HHS page now notes that order at its top.
Attorney General of the State of New York and The NewYork-Presbyterian Hospital (settlement)
New York Attorney General
Agency action
The Attorney General secured $300,000 from the hospital over advertising tools on its website that sent visitors' private information, including health-related details from doctor searches and appointment bookings, to third-party technology companies, and required it to audit and test such tools before using them and to instruct third parties to delete protected health information.
In re Meta Pixel Healthcare Litigation (Doe v. Meta Platforms, Inc.)
U.S. District Court for the Northern District of California, 690 F. Supp. 3d 1064, No. 3:22-cv-03580-WHO, ECF No. 316
Mixed ruling
The court denied Meta's motion to dismiss the patients' federal Wiretap Act, California Invasion of Privacy Act, breach of contract and unjust enrichment claims, holding that they adequately alleged that covered content was transferred and leaving the boundaries of that content to a full evidentiary record.
U.S. District Court for the Northern District of Illinois, 683 F. Supp. 3d 836, No. 1:22-cv-05380
Mixed ruling
The court dismissed the federal Wiretap Act count because the allegations were too vague to infer that the hospital disclosed individually identifiable health information rather than metadata, but it let an Illinois Eavesdropping Act count proceed on the theory that the hospital knowingly derived a benefit from third parties' use of cookies on its web properties.
Later history: On amended allegations the court held on December 11, 2023 that the Wiretap Act claim was stated, denied judgment on the pleadings on that claim and the Eavesdropping Act claim on July 18, 2024, and granted final approval of a class settlement providing injunctive relief only on December 17, 2024.
Joint letters to hospital systems and telehealth providers
Federal Trade Commission and U.S. Department of Health and Human Services, Office for Civil Rights
Guidance
The FTC and the HHS Office for Civil Rights wrote to approximately 130 hospital systems and telehealth providers warning that online tracking technologies may be impermissibly disclosing consumers' sensitive personal health data to third parties.
The FTC issued a final order banning the online counseling service from sharing consumers' health data for advertising and requiring it to pay $7.8 million for partial consumer refunds, settling charges that it disclosed consumers' email addresses, IP addresses and health questionnaire information to advertising companies.
The FTC announced final approval on July 14, 2023. BetterHelp did not admit or deny the allegations.
Federal Trade Commission, through the Department of Justice; U.S. District Court for the Northern District of Illinois, No. 1:23-cv-03107
Agency action
The court entered a stipulated order requiring the developer of the Premom fertility app to pay a $100,000 civil penalty for violating the Health Breach Notification Rule and permanently prohibiting it from sharing users' personal health data with third parties for advertising, over charges that it disclosed users' sensitive health data to third-party analytics and advertising companies and failed to notify consumers of those unauthorized disclosures.
The FTC announced the case on May 17, 2023, and in a related action the company agreed to pay a total of $100,000 to Connecticut, the District of Columbia and Oregon.
Federal Trade Commission, through the Department of Justice; U.S. District Court for the Northern District of California, No. 3:23-cv-00460-DMR
Agency action
In the FTC's first enforcement action under its Health Breach Notification Rule, the court entered a stipulated order requiring GoodRx to pay a $1.5 million civil penalty for failing to notify consumers of unauthorized disclosures of their health information to advertising companies and other third parties, and barring it from disclosing user health information to third parties for advertising.
The FTC announced the case on February 1, 2023. GoodRx did not admit or deny the allegations.
Source: FTC case page. Checked on November 10, 2026.
The FTC finalized a settlement requiring the company to obtain the affirmative consent of users of its fertility tracking app before sharing their personal health information with others, notify affected users, and instruct any third party that received users' health information to destroy it, over allegations that despite promising to keep users' health data private, it shared sensitive health data with marketing and analytics firms.
The Commission voted 4-0-1 to finalize the settlement, which also requires an independent review of the company's privacy practices.